Mia's Feed
Medical News & Research

New Book Explores the Benefits and Risks of Ibuprofen

New Book Explores the Benefits and Risks of Ibuprofen

Share this article

A comprehensive new book by UC Davis researchers explores the beneficial effects and potential risks of ibuprofen, highlighting the importance of informed use and communication about this commonly used painkiller.

2 min read

A recent publication sheds light on the multifaceted effects of ibuprofen, one of the most commonly used over-the-counter pain relievers worldwide. Led by Professor Aldrin Gomes from UC Davis, along with a team of 36 students and researchers, the book offers an in-depth examination of both the positive and negative impacts of this widely utilized medication.

Ibuprofen has revolutionized pain management, providing an affordable and accessible remedy for headaches, fever, and inflammation. However, beneath its widespread use lies a complex profile of potential health risks. Studies have indicated that regular, daily use of ibuprofen may increase the risk of stroke by threefold, with other research suggesting rises of 10% to 50% in stroke risk shortly after initiation of treatment. The medication is also associated with other adverse effects, including heart attack, heart failure, and gastrointestinal bleeding.

Beyond individual health impacts, ibuprofen interacts with over 400 prescription drugs, posing risks of drug interactions. Environmental concerns are also highlighted, as discarded pills can be toxic to pets and aquatic ecosystems, affecting fish and plant life.

The motivation behind the book stemmed from Gomes’ observations that students entering his lab often lacked awareness of ibuprofen’s potential negative effects. To address this knowledge gap, the project became a collaborative effort involving students in research, writing, editing, and illustrating. The process has not only enhanced their understanding of pharmacology but also emphasized the importance of science communication.

The book covers how ibuprofen functions to alleviate pain, reduce inflammation, and bring down fevers. It discusses how the medication can impact vital organs such as the heart, liver, kidneys, and gastrointestinal system. Importantly, it offers guidance on responsible use of painkillers and explores natural alternatives for pain management.

Published on June 3 by Mystic River Books, "The Comprehensive Guide to Ibuprofen: The Good, the Bad and the Unexpected" is available in various formats including e-book, paperback, and hardcover. The publication aims to educate the public about the balanced benefits and risks associated with this essential drug.

For more information, the original article can be referenced at https://medicalxpress.com/news/2025-06-good-bad-unexpected-ibuprofen.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Rising Incidence of Skin Cancer Among Older Men as Global Population Ages

Skin cancer rates among older men are rising globally, driven by demographic shifts and increased ultraviolet exposure. Learn about recent research on this growing health concern and the importance of early detection and prevention.

Health Disparities in US Territories: Puerto Rico Reports Highest Rates of Poor Physical Health Compared to All 50 States

New research uncovers significant health disparities in US territories like Puerto Rico, with residents experiencing the highest rates of poor physical health compared to the 50 states. Data inclusion is vital for effective health policy. | source: https://medicalxpress.com/news/2025-05-health-disparities-territories-puerto-rico.html

Innovative Dual-Mode Optical Imaging System Enhances Noninvasive Skin Cancer Diagnosis

A revolutionary dual-mode optical imaging system combines high-resolution structural imaging with chemical analysis, offering a noninvasive method for more accurate skin cancer diagnosis and monitoring.

Guselkumab Shows Promising Results in Treating Crohn's Disease with Superior Efficacy in Clinical Trials

Clinical trials show guselkumab outperforms existing treatments in promoting intestinal healing and symptom relief in Crohn's disease, offering new hope through targeted IL-23 inhibition.